KTTA logo

Pasithea Therapeutics (KTTA) Company Overview

Profile

Full Name:

Pasithea Therapeutics Corp.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 15, 2021

Indexes:

Not included

Description:

Pasithea Therapeutics (KTTA) is a biotechnology company focused on developing innovative treatments for mental health disorders. They aim to create new therapies that target the underlying causes of conditions like depression and anxiety, improving patients' quality of life through advanced research and development.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 30, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 2, 2024

Analyst ratings

Recent major analysts updates

Jul 10, 23 EF Hutton
Buy
Apr 3, 23 EF Hutton
Buy
Dec 14, 21 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Pasithea Therapeutics?
  • Does Pasithea Therapeutics pay dividends?
  • What sector is Pasithea Therapeutics in?
  • What industry is Pasithea Therapeutics in?
  • What country is Pasithea Therapeutics based in?
  • When did Pasithea Therapeutics go public?
  • Is Pasithea Therapeutics in the S&P 500?
  • Is Pasithea Therapeutics in the NASDAQ 100?
  • Is Pasithea Therapeutics in the Dow Jones?
  • When was Pasithea Therapeutics's last earnings report?
  • When does Pasithea Therapeutics report earnings?
  • Should I buy Pasithea Therapeutics stock now?

What is the ticker symbol for Pasithea Therapeutics?

The ticker symbol for Pasithea Therapeutics is NASDAQ:KTTA

Does Pasithea Therapeutics pay dividends?

No, Pasithea Therapeutics does not pay dividends

What sector is Pasithea Therapeutics in?

Pasithea Therapeutics is in the Healthcare sector

What industry is Pasithea Therapeutics in?

Pasithea Therapeutics is in the Biotechnology industry

What country is Pasithea Therapeutics based in?

Pasithea Therapeutics is headquartered in United States

When did Pasithea Therapeutics go public?

Pasithea Therapeutics's initial public offering (IPO) was on September 15, 2021

Is Pasithea Therapeutics in the S&P 500?

No, Pasithea Therapeutics is not included in the S&P 500 index

Is Pasithea Therapeutics in the NASDAQ 100?

No, Pasithea Therapeutics is not included in the NASDAQ 100 index

Is Pasithea Therapeutics in the Dow Jones?

No, Pasithea Therapeutics is not included in the Dow Jones index

When was Pasithea Therapeutics's last earnings report?

Pasithea Therapeutics's most recent earnings report was on Nov 13, 2024

When does Pasithea Therapeutics report earnings?

The next expected earnings date for Pasithea Therapeutics is May 14, 2025

Should I buy Pasithea Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions